Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Tribune News Service
Tribune News Service
National
Noah Goldberg

Sarah Palin tests positive for COVID on first day of New York Times defamation trial

NEW YORK — Former Alaska Gov. Sarah Palin tested positive for coronavirus just as jury selection got underway Monday in her defamation trial against the New York Times.

The positive result from a rapid COVID test means the trial could be delayed to Feb. 3. Attorneys for Palin and The Times were debating in Manhattan Federal Court how to proceed.

”Ms. Palin had tested positive for coronavirus. She is, of course, unvaccinated,” Judge Jed Rakoff announced in court, according to reporters in the courtroom.

Palin proclaimed in December she would get vaccinated “over my dead body.”

Palin sued The Times in 2017, claiming an editorial, “America’s Lethal Politics,” defamed her by wrongly linking ads from her political action committee to the 2011 shooting of Rep. Gabrielle Giffords (D-Ariz.).

The Times editorial incorrectly stated that ads by Palin’s PAC put “Giffords and 19 other Democrats under stylized crosshairs.”

But the crosshairs were actually over images of electoral districts rather than individual politicians.

The Times ran a correction. Former Opinion editor James Bennet, who resigned in 2020, and the newspaper itself, are named as defendants in the lawsuit.

Rakoff said Palin could observe jury selection over a video feed and testify in person once she’s recovered. Jury selection could also proceed occur without her there at all if she agreed, the judge said.

But Palin’s lawyer asked for delay, saying his client wanted to be there in-person for the trial.

Palin was set to get another COVID test Monday morning to confirm the diagnosis.

____

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.